Literature DB >> 10419193

Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity.

H S Hansen1, B Moesgaard, H H Hansen, A Schousboe, G Petersen.   

Abstract

N-Acyl-phosphatidylethanolamine (NAPE) is present in very small amounts in mammalian tissues (less than 0.1% of total phospholipids). However, NAPE as well as its degradation product, N-acylethanolamine (NAE), can be formed in certain neuronal tissues in response to increased [Ca2+]i. A high [Ca2+]i will activate the NAPE-forming N-acyltransferase using the sn-1 acyl group of a donor phospholipid as substrate in the transfer reaction. This membrane-bound enzyme seems to have no substrate specificity with respect to transfer of acyl groups; thus the fatty acids in the N-acyl group of NAPE are mainly 16:0 and 18:1, corresponding to the fatty acids in the sn-1 acyl group of the donor phospholipids. The NAPE-hydrolyzing phospholipase D also seems not to be acyl-group specific. In mouse neocortical neurons in primary culture, formation of NAPE and NAE is stimulated by glutamate via activation of the N-methyl-D-aspartate-receptor. Both NAPE and, to a lesser extent, NAE accumulate in a linear fashion for many hours while at the same time the neurons are dying. Likewise, in neurons prelabeled with 14C-arachidonic acid, 14C-arachidonic acid-labeled NAPE, and anandamide (= N-arachidonoylethanolamine) are accumulating. The formation of NAPE and NAE may represent a cytoprotective response in relation to various forms of neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419193     DOI: 10.1007/BF02562333

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.646


  36 in total

1.  Anandamide and other N-acylethanolamines in mouse peritoneal macrophages.

Authors:  P C Schmid; T Kuwae; R J Krebsbach; H H Schmid
Journal:  Chem Phys Lipids       Date:  1997-07-14       Impact factor: 3.329

Review 2.  N-acylated glycerophospholipids and their derivatives.

Authors:  H H Schmid; P C Schmid; V Natarajan
Journal:  Prog Lipid Res       Date:  1990       Impact factor: 16.195

Review 3.  Formation of N-acyl-phosphatidylethanolamines and N-acetylethanolamines: proposed role in neurotoxicity.

Authors:  H S Hansen; L Lauritzen; B Moesgaard; A M Strand; H H Hansen
Journal:  Biochem Pharmacol       Date:  1998-03-15       Impact factor: 5.858

4.  Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells.

Authors:  T Sugiura; T Kodaka; S Kondo; S Nakane; H Kondo; K Waku; Y Ishima; K Watanabe; I Yamamoto
Journal:  J Biochem       Date:  1997-10       Impact factor: 3.387

5.  Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture.

Authors:  H S Hansen; L Lauritzen; A M Strand; B Moesgaard; A Frandsen
Journal:  Biochim Biophys Acta       Date:  1995-10-05

6.  N-palmitoylphosphatidylethanolamine stabilizes liposomes in the presence of human serum: effect of lipidic composition and system characterization.

Authors:  M Mercadal; J C Domingo; M Bermudez; M Mora; M A De Madariaga
Journal:  Biochim Biophys Acta       Date:  1995-05-04

7.  Biosynthesis of N-acylethanolamine phospholipids by dog brain preparations.

Authors:  V Natarajan; P C Schmid; P V Reddy; M L Zuzarte-Augustin; H H Schmid
Journal:  J Neurochem       Date:  1983-11       Impact factor: 5.372

8.  N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain.

Authors:  V Natarajan; P C Schmid; H H Schmid
Journal:  Biochim Biophys Acta       Date:  1986-08-14

9.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

Authors:  R Mechoulam; S Ben-Shabat; L Hanus; M Ligumsky; N E Kaminski; A R Schatz; A Gopher; S Almog; B R Martin; D R Compton
Journal:  Biochem Pharmacol       Date:  1995-06-29       Impact factor: 5.858

10.  Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type.

Authors:  P C Schmid; P V Reddy; V Natarajan; H H Schmid
Journal:  J Biol Chem       Date:  1983-08-10       Impact factor: 5.157

View more
  12 in total

1.  Covalent modification of lipids and proteins in rat hepatocytes and in vitro by thioacetamide metabolites.

Authors:  Diganta Sarma; Heather Hajovsky; Yakov M Koen; Nadezhda A Galeva; Todd D Williams; Jeffrey L Staudinger; Robert P Hanzlik
Journal:  Chem Res Toxicol       Date:  2012-06-15       Impact factor: 3.739

2.  N-Myristoylated Phosphatidylethanolamine: Interfacial Behavior and Interaction with Cholesterol.

Authors:  Xin-Min Li; M Ramakrishnan; Howard L Brockman; Rhoderick E Brown; Musti J Swamy
Journal:  Langmuir       Date:  2002-01-08       Impact factor: 3.882

Review 3.  Cannabinoids and neuroprotection in basal ganglia disorders.

Authors:  Onintza Sagredo; Moisés García-Arencibia; Eva de Lago; Simone Finetti; Alessandra Decio; Javier Fernández-Ruiz
Journal:  Mol Neurobiol       Date:  2007-06-23       Impact factor: 5.590

4.  Cannabis and endocannabinoid modulators: Therapeutic promises and challenges.

Authors:  Igor Grant; B Rael Cahn
Journal:  Clin Neurosci Res       Date:  2005

5.  N-Acylphosphatidylethanolamine accumulation in potato cells upon energy shortage caused by anoxia or respiratory inhibitors.

Authors:  A J Rawyler; R A Braendle
Journal:  Plant Physiol       Date:  2001-09       Impact factor: 8.340

6.  Exogenous anandamide protects rat brain against acute neuronal injury in vivo.

Authors:  M van der Stelt; W B Veldhuis; G W van Haaften; F Fezza; T Bisogno; P R Bar; G A Veldink; J F Vliegenthart; V Di Marzo; K Nicolay
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

Review 7.  Acute neuronal injury, excitotoxicity, and the endocannabinoid system.

Authors:  Mario van der Stelt; Wouter B Veldhuis; Mauro Maccarrone; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Vincenzo Di Marzo; Johannes F G Vliegenthart
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

Review 8.  Therapeutic potential of cannabinoids in CNS disease.

Authors:  J Ludovic Croxford
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 9.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 10.  Role of cannabinoids and endocannabinoids in cerebral ischemia.

Authors:  Cecilia J Hillard
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.